Drug profile · INN
casirivimab and imdevimab
RONAPREVE (NOTE 2) INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
casirivimab and imdevimab (RONAPREVE (NOTE 2) INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN casirivimab and imdevimab
Brand RONAPREVE (NOTE 2) INITIAL APPROVAL
Frequently asked questions
What is casirivimab and imdevimab?
casirivimab and imdevimab (RONAPREVE (NOTE 2) INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for casirivimab and imdevimab?
RONAPREVE (NOTE 2) INITIAL APPROVAL is a marketed brand name for casirivimab and imdevimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.